EcoDrugPlus

Heat Shock Protein 90 Alpha Family Class B Member 1

Ensembl ID : ENSCMIG00000017039
Gene Symbol: HSP90AB1
3 Cross references
359 Possible Orthologues:

Histone Deacetylase 11

Ensembl ID : ENSCMIG00000011388
Gene Symbol: HDAC11
4 Cross references
201 Possible Orthologues:

Histone Deacetylase 2

Ensembl ID : ENSCMIG00000004990
Gene Symbol: HDAC2
2 Cross references
205 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSCMIG00000014214
Gene Symbol: HDAC4
4 Cross references
265 Possible Orthologues:

Histone Deacetylase 5

Ensembl ID : ENSCMIG00000007629
Gene Symbol: HDAC5
4 Cross references
196 Possible Orthologues:

Histone Deacetylase 8

Ensembl ID : ENSCMIG00000003634
Gene Symbol: HDAC8
3 Cross references
206 Possible Orthologues:

Histone Deacetylase 9

Ensembl ID : ENSCMIG00000006553
Gene Symbol: HDAC9
3 Cross references
234 Possible Orthologues:

Hydroxycarboxylic Acid Receptor 1

Ensembl ID : ENSCMIG00000006413
Gene Symbol: HCAR1
3 Cross references
320 Possible Orthologues:

Hydroxysteroid 11-Beta Dehydrogenase 1

Ensembl ID : ENSCMIG00000002980
Gene Symbol: HSD11B1
4 Cross references
284 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 4

Ensembl ID : ENSCMIG00000011814
Gene Symbol: HCN4
2 Cross references
289 Possible Orthologues:

Hypocretin Receptor 2

Ensembl ID : ENSCMIG00000016689
Gene Symbol: HCRTR2
4 Cross references
201 Possible Orthologues:

Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 Homolog

Ensembl ID : ENSCMIG00000005006
Gene Symbol: LOC103172502
2 Cross references
245 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).